Skip Navigation
Skip to contents

KDDW 2018

d-Day
D0

  • Advancing Gastroenterology and Hepatology through Creative Integration
  • Abstract Submission and Registration are available via APDW 2018 website (www.apdw2018.org)

Program Details

Home    >    Scientific Program    >    Program Details
Symposium GI-K-01 (UG)
Nov. 15 (Thu)
09:00-10:30
Prevention of gastric cancer 203 (2F)
Chairperson(s) Sang Young Seol (Busan), Jae J Kim (Seoul)
09:00-09:20 Primary prevention: role of H. pylori eradication Kee Don Choi
(Seoul)
09:20-09:40 Secondary prevention: role of H. pylori eradication after endoscopic resection of gastric epithelial neoplasia Hiroto Miwa
(Nishinomiya)
09:40-10:00 Secondary prevention: role of H. pylori eradication after partial gastrectomy Da Hyun Jung
(Seoul)
10:00-10:20 Chemoprevention of gastric cancer other than H. pylori eradication Soo-Jeong Cho
(Seoul)
10:20-10:30 Q&As
Free Paper (UG 1) (Korean & English)
Nov. 15 (Thu)
09:00-10:30
KDDW Free Paper (UG 01) E3+4 (3F)
Chairperson(s) Sung Joon Lee (Chuncheon), Sun-Young Lee (Seoul)
09:00-09:10 Development of LGR5-targeting peptide probe and validation in gastric cancer cells Jae Myung Park
(Seoul)
09:10-09:20 Circular RNA_009414 /miR-30c-2-3p axis promotes gastric cancer via BCL9/Wnt/-catenin signaling pathway Xuan Li
(Nanjing)
09:20-09:30 Dietary and physical activity effect on gastric cancer in multi-center prospective registry Su Youn Nam
(Daegu)
Chairperson(s) Jin Il Kim (Seoul), Chan Gyoo Kim (Goyang)
09:30-09:40 Application of artificial intelligence (AI) technology for the prediction of invasion depth in early gastric cancer (EGC) Hong Jin Yoon
(Seoul)
09:40-09:50 M1a disease should be reconsidered in esophageal cancer staging system from the perspective of treatment response and survival after definitive concurrent chemoradiotherapy Tae Ryong Chung
(Seoul)
Free Paper (Motility 1) (Korean)
Nov. 15 (Thu)
09:00-10:30
KDDW Free Paper (Motility 01) E5 (3F)
Chairperson(s) Young Woo Kang (Daejeon), Hye-Kyung Jung (Seoul)
09:00-09:10 Identification of genetic factors associated with reflux esophagitis using a genome-wide association study in the Korean population Eun Hyo Jin
(Seoul)
09:10-09:20 Gender differences in association between waist circumference and the risk of reflux esophagitis Hyo-Joon Yang
(Seoul)
09:20-09:30 Gastroesophageal reflux disease in subjects with sleep disordered breathing Min Jae Cho
(Seoul)
Chairperson(s) Sung Pyo Hong (Seongnam), Kyung Sik Park (Daegu)
09:30-09:40 Association between skeletal muscle attenuation and gastroesophageal reflux disease : A health check-up cohort study Young Min Kim
(Seoul)
09:40-09:50 The effect of rebamipide in patients with gastroesophageal reflux disease, including non-erosive reflux disease: a multi-center, randomized, single-blind, placebo-controlled study (RENERD Study) Soon Man Yoon
(Cheongju)
09:50-10:00 Prophylactic anti-reflux surgery after laparoscopic gastric wedge resections for gastric submucosal tumors of gastroesophageal junction Chang Hyun Kim
(Incheon)
Symposium GI-K-02 (Motility)
Nov. 15 (Thu)
11:00-12:30
Dyspepsia: what’s new in 2018? (ANMA-KSNM joint session) 203 (2F)
Chairperson(s) Hyojin Park (Seoul), Oh Young Lee (Seoul)
11:00-11:20 Epidemiology of functional dyspepsia in Asia Hyojin Park
(Seoul)
11:20-11:40 New pathogenesis of functional dyspepsia Kwang Jae Lee
(Suwon)
11:40-12:00 Helicobacter pylori-associated dyspepsia Kentaro Sugano
(Shimotsuke)
12:00-12:20 Novel treatment of dyspepsia Justin CY Wu
(Hong Kong)
12:20-12:30 Q&As
PG Course-GI Cancer (Korean)
Nov. 15 (Thu)
11:00-12:30
Update and change of health insurance coverage for gastrointestinal cancer in Korea 2018 E1+2 (3F)
Chairperson(s) Kwang Ro Joo (Seoul), Sung Soo Kim (Uijeongbu)
11:00-11:20 Esophageal/ stomach cancer Hee Seok Moon
(Daejeon)
11:20-11:40 Colorectal cancer Jae Jun Park
(Seoul)
11:40-12:00 Pancreatobiliary cancer Sang Myung Woo
(Goyang)
12:00-12:20 Palliative care for gastrointestinal cancer - pain, anti-emetics, nutrition Bong Eun Lee
(Busan)
12:20-12:30 Q&As
Free Paper (UG 2) (Korean)
Nov. 15 (Thu)
11:00-12:30
KDDW Free Paper (UG 02) E3+4 (3F)
Chairperson(s) Ok-Jae Lee (Jinju), Tae Ho Kim (Bucheon)
11:00-11:10 The Utility of Endoscopic submucosal dissection(ESD) with laparoscopic sentinel lymph node dissection(ESN) and endoscopic full-thickness gastric resection with laparoscopic sentinel lymph node dissection in patients beyond the indications of ESD Junsu Chang
(Sungnam)
11:10-11:20 Clinical outcomes of gastric cardia cancer during a recent decade of Korea Seonhoo Kim
(Suwon)
11:20-11:30 The effect of metformin on prognosis in patients with locally advanced gastric cancer associated with type 2 diabetes mellitus. Ho Seok Seo
(Seoul)
Chairperson(s) Gwang Ho Baik (Chuncheon), Byung-Hoon Min (Seoul)
11:30-11:40 Long-term outcome of Helicobacter pylori-negative and Pepsinogen-positive group D patients of health checkup Koreans Yoo Min Han
(Seoul)
11:40-11:50 Should the triple therapy be thrown away for Helicobacter pylori eradication? ; Efficacy of metronidazole-containing triple therapy after Clarithromycin-contaning triple therapy failure Chang Min Lee
(Jinju)
11:50-12:00 A 7 day triple therapy efficacy is similar with 14-day therapy for the eradication of Helicobacter Pylori with no point mutation in 23S rRNA Hyeong Jin Kim
(Yangsan)
12:00-12:10 Walnut phenolic extract inhibited Helicobacter pylori-induced STAT3 phosphorylation through activation of PPAR-gamma Jeong-Min An
(Seongnam)
PG Course-UG
Nov. 15 (Thu)
14:00-15:30
Overview of recent progress in upper GI diseases 103 (1F)
Chairperson(s) Jaw-Town Lin (Taipei), Myung-Gyu Choi (Seoul)
14:00-14:20 Diagnosis and treatment of GERD Sabine Roman
(Lyon)
14:20-14:40 Management of peptic ulcer disease Joseph J Y Sung
(Hong Kong)
14:40-15:00 Helicobacter pylori eradication in Asia-Pacific regions Jaw-Town Lin
(Taipei)
15:00-15:20 Effect of screening endoscopy for gastric cancer in regions where Helicobacter pylori is prevalent Soo-Jeong Cho
(Seoul)
15:20-15:30 Q&As
PG Course-Motility (Korean)
Nov. 15 (Thu)
14:00-15:30
A to Z of constipation E1+2 (3F)
Chairperson(s) Sei Jin Youn (Cheongju), Joonseong Lee (Seoul)
14:00-14:20 Pathophysiology Jeong Eun Shin
(Cheonan)
14:20-14:40 Assessment Seong-Eun Kim
(Seoul)
14:40-15:00 Pharmacologic treatment Kee Wook Jung
(Seoul)
15:00-15:20 Nonpharmacologic treatment Tae Hee Lee
(Seoul)
15:20-15:30 Q&As
Free Paper (UG 3) (Korean & English)
Nov. 15 (Thu)
14:00-15:30
KDDW Free Paper (UG 03) E5 (3F)
Chairperson(s) Jin Tae Jung (Daegu), Cheol Woong Choi (Yangsan)
14:00-14:10 The increasing incidence and identifying biomarkers of eosinophilic esophagitis in Korea Ga Hee Kim
(Seoul)
14:10-14:20 Peroral endoscopic myotomy for the treatment of achalasia: Procedural outcomes in elderly and not elderly patients Ju Sung Kim
(Seongnam)
14:20-14:30 Stomach property with stress and strain depending on location and direction for developing virtual stomach model Seung Han Kim
(Seoul)
14:30-14:40 The expression of H+,K+-ATPase and interleukin-1B according to H. pylori infection and intestinal metaplasia Hee Jin Kim
(Seongnam)
Chairperson(s) Sok Won Han (Bucheon), Dae Young Cheung (Seoul)
14:40-14:50 High risk factors for upper gastrointestinal malignancy among patients presenting with dysphagia: Analysis of patients who presented a tertiary care center in Sri Lanka Nadeesha Jeewan Nawarathna
(Mawanella)
14:50-15:00 Risk factor for peptic ulcer in Buddhist priests compared to general population : A cross-sectional, case-control study Sung Hun Choi
(Goyang)
15:00-15:10 BST-104, a water extract of lonicera japonica, has a gastroprotective effect through antioxidant and anti-inflammatory actions Jongbeom Shin
(Incheon)
15:10-15:20 DM remission rate after sleeve or bypass; utilizing individualized metabolic surgery (IMS) score for Korean obese patients Dae Geun Park
(Seoul)
PG Course-LG
Nov. 15 (Thu)
16:00-17:30
Recent update in lower GI diseases 103 (1F)
Chairperson(s) Peter Gibson (Melbourne), Tae Il Kim (Seoul)
16:00-16:20 The cutting edge strategy for the treatment of inflammatory bowel disease therapy Choon Jin Ooi
(Singapore)
16:20-16:40 Quality issues in colonoscopic screening for colorectal cancer Uri Ladabaum
(Redwood)
16:40-17:00 Treatment of IBS: low-FODMAP diet and beyond Peter Gibson
(Melbourne)
17:00-17:20 Upates in diagnosis and treatment for Clostridium difficile infection You Sun Kim
(Seoul)
15:20-15:30 Q&As
Symposium GI-K-03 (LG)
Nov. 15 (Thu)
16:00-17:30
Recent progress on translational research in colorectal neoplasm 203 (2F)
Chairperson(s) Yoon Tae Jeen (Seoul), Joseph J Y Sung (Hong Kong)
16:00-16:20 Novel biomarkers of noninvasive diagnosis of colorectal cancer: Fecal microbiota Joseph J Y Sung
(Hong Kong)
16:20-16:40 Optimal strategy of colorectal cancer screening in Asia Han-Mo Chiu
(Taipei)
16:40-17:00 Emerging imaging techniques for colorectal neoplasm Seung-Jae Myung
(Seoul)
17:00-17:20 New targeting agents for treatment of colorectal neoplasm Jae Hyun Kim
(Busan)
15:20-15:30 Q&As
PG Course-UG (Korean)
Nov. 15 (Thu)
16:00-17:30
Unmet needs in upper gastrointestinal diseases E1+2 (3F)
Chairperson(s) Jong Sun Rew (Gwangju), Jong-Jae Park (Seoul)
16:00-16:20 소화성궤양 합병증: 어떻게 대처할 것인가? Ju Yup Lee
(Daegu)
16:20-16:40 조기위암의 내시경적 절제술: 그 다음 이야기 Wan-Sik Lee
(Gwangju)
16:40-17:00 불응성 역류성 식도염: 무엇을 더 해야 하나? Moo-In Park
(Busan)
17:00-17:20 위축성위염, 장상피화생, 그리고 이형성: 단계별 추적검사 Woo Chul Chung
(Suwon)
15:20-15:30 Q&As
Free Paper (Motility 2) (Korean)
Nov. 15 (Thu)
16:00-17:30
KDDW Free Paper (Motility 02) E5 (3F)
Chairperson(s) Joong Goo Kwon (Daegu), Yong Sung Kim (Iksan)
16:00-16:10 Endoflip(Endolumenal Functional Lumen Imaging Probe) in diagnosis of gastroesophageal reflux disease Eunju Kim
(Seongnam)
16:10-16:20 pH impedance and high resolution esophageal manometry in symptomatic patients with cervical inlet patch Tae Hee Lee
(Seoul)
16:20-16:30 Relationship between gender roles and psychiatric factors in patients with irritable bowel syndrome Jung Hwan Oh
(Seoul)
Chairperson(s) Chong-Il Sohn (Seoul), Jung Hwan Oh (Seoul)
16:30-16:40 A newly developed minimally invasive wireless gastrostimulator : A pilot study Sang Hoon Kim
(Seoul)
16:40-16:50 Clinical characteristics of achalasia with normal IRP and outcomes after POEM Eunju Kim
(Seongnam)
16:50-17:00 Epidemiology and incidence of achalasia in korea based on nationwide big data: From conventional to high-resolution manometry era Ga Hee Kim
(Seoul)
Symposium GI-01 (Motility)
Nov. 16 (Fri)
08:30-10:00
Updates in gastrointestinal neurogastro-motility disorders 105 (1F)
Chairperson(s) Nicholas J Talley (Newcastle), Kwang Jae Lee (Suwon)
08:30-08:50 Approach to esophageal disorders John Pandolfino
(Wilmette)
08:50-09:10 Approach to gastric disorders Nicholas J Talley
(Newcastle)
09:10-09:30 Approach to bowel disorders Eamonn Quigley
(Houston)
09:30-09:50 Differences of guidelines between Asia and West Jung-Ho Park
(Seoul)
09:50-10:00 Q&As
Free Paper (GI Cancer 1) (Korean)
Nov. 16 (Fri)
08:30-10:00
KDDW Free Paper (GI Cancer 01) E4 (3F)
Chairperson(s) Jin Tae Jung (Daegu), Su Youn Nam (Daegu)
08:30-08:40 Effects of a 12 week home-based exercise program in patients with high risk of gastric cancer: A pilot study Jeung Eun Lee
(Seoul)
08:40-08:50 Subepithelial spread of early gastric signet ring cell carcinoma: How far they can reach? Sun Hyung Kang
(Daejeon)
08:50-09:00 Gastric cancer with lymph node metastasis more than 15 (N3b): is it really stage III disease? Sa-Hong Kim
(Seoul)
09:00-09:10 Predictive factors of lymph node metastasis in early gastric cancer patients with Seiwert type II/III Min Young Son
(Busan)
09:10-09:20 Abdominal computed tomography compared with endoscopic ultrasound sonography for the diagnosis of gastric subepithelial tumors Cheal Wung Huh
(Incheon)
Chairperson(s) Eun Kwang Choi (Jeju), Seung-Ok Lee (Jeonju)
09:30-09:40 Incidence and prognosis of subsequent cholangiocarcinoma in patients with hepatic resection for bile duct stones Seon Mee Park
(Cheongju)
09:40-09:50 Validation of the 8th edition of the American Joint Commission on Cancer (AJCC) staging system for pancreatic adenocarcinoma: Using Korean pancreatic cancer (K-PAC) registry Dong Woo Shin
(Seongnam)
09:50-10:00 Clinicopathologic characteristics of Intraductal Papillary Neoplasm of Bile duct (IPNB) after central review: Korean multi-center collaboration study Jae Ri Kim
(Seoul)
10:00-10:10 Adjuvant gemcitabine-based chemotherapy vs concurrent chemoradiotherapy after R0 resection for pancreatic ductal adenocarcinoma: A propensity score-matched analysis Min Su You
(Seoul)
Free Paper (LG 1) (Korean)
Nov. 16 (Fri)
08:30-10:00
KDDW Free Paper (LG 01) E5 (3F)
Chairperson(s) Kyu Chan Huh (Daejeon), Sung-Ae Jung (Seoul)
08:30-08:40 A trial for the administration of a functionally enhanced tonsil-derived mesenchymal stem cells in a chronic colitis model. Yang Hee Joo
(Seoul)
08:40-08:50 The ability of epithelial regeneration is reduced in the Crohn's disease patient-derived organoids, especially in TNF-alpha enriched condition. Sung Noh Hong
(Seoul)
08:50-09:00 Diagnostic role of NOD signaling and apoptosis tests in patients with XIAP-deficient IBD Seak Hee Oh
(Seoul)
09:00-09:10 Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers Soo-Kyung Park
(Seoul)
09:10-09:20 Identification of prominent hub genes of colorectal cancer : Using network analysis of gene expression data Seong Ji Choi
(Seoul)
Chairperson(s) Byong Duk Ye (Seoul), Geom Seog Seo (Iksan)
09:20-09:30 Vegetarianism as a protective factor for asymptomatic colonic diverticulosis; A cross-sectional, case-control study between Buddhist priests and general population Jihun Bong
(Goyang)
09:30-09:40 Clinical outcome after endoscopic decompression of sigmoid volvulus; A multicenter-retrospective study, Daejeon-Chungchung intestinal research group Hee Seok Moon
(Daejeon)
09:40-09:50 Identification and validation of a peptide probe binding specifically to colon cancer cells Younghee Choe
(Seoul)
Free Paper (LG 2) (Korean & English)
Nov. 16 (Fri)
10:20-11:10
KDDW Free Paper (LG 02) E5 (3F)
Chairperson(s) Jin-Oh Kim (Seoul), Chang Hwan Choi (Seoul)
10:20-10:30 Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin Kyung Mo Yoo
(Seoul)
10:30-10:40 Clinicopathological features of malignant tumors of small bowel diagnosed by video capsule endoscopy and balloon-assisted enteroscopy: A single center experience Sunghee Kam
(Seoul)
10:40-10:50 Modifiable lifestyle risk factors and the risk of colorectal neoplasia recurrence Kyungjin Ko
(Seoul)
10:50-11:00 Differences in the clinicopathologic characteristics between right- and left-sided colon cancer Hannah Ra
(Incheon)
11:00-11:10 Epidemiology of colorectal cancer in Northern Malaysia: A 7-year review (2008-2014) Mohamad Fadli Abd Rahman
(Alor Setar)
Free Paper (GI Cancer 2) (Korean & English)
Nov. 16 (Fri)
10:30-12:00
KDDW Free Paper (GI Cancer 02) E4 (3F)
Chairperson(s) Yun Jeong Lim (Goyang), Bora Keum (Seoul)
10:30-10:40 Changing trends of colonoscopic burden: A nationwide population-based study in Korea Jae Myung Cha
(Seoul)
10:40-10:50 Risk of developing colorectal cancer based on the prior screening behaviors: Population-based cohort study. Su Young Kim
(Wonju)
10:50-11:00 Colorectal cancer screening among cancer survivors in the US Adeyinka O Laiyemo
(Washington)
11:00-11:10 Metabolically healthy obesity is associated with an increased risk of colorectal neoplasia recurrence Hyun Beom Chae
(Seoul)
11:10-11:20 Association between low relative muscle mass and the risk of colorectal neoplasia recurrence in Korean men and women Kyung Mo Yoo
(Seoul)
Chairperson(s) Jin-Hyeok Hwang (Seongnam), Jae Hee Cho (Incheon)
11:20-11:30 Neoadjuvant FOLFIRINOX in patients with locally advanced pancreatic cancer Young Hoon Choi
(Seoul)
11:30-11:40 Lymphocyte-to-monocyte ratio is a valuable marker for predicting survival in patients with gallbladder cancer undergoing chemotherapy compared to neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio Young Hoon Choi
(Seoul)
11:40-11:50 Clinicopathologic characteristics and kras molecular alterations of adenosquamous carcinoma of the pancreas compared to pancreatic ductal adenocarcinoma Sun Mi Lee
(Jeju)
11:50-12:00 Detection of circulating tumor DNA and its application in pancreatic cancer patients Joo Kyung Park
(Seoul)
Topic Forum (LG) (Korean)
Nov. 16 (Fri)
11:10-12:00
Topic Forum (LG) E5 (3F)
Chairperson(s) Hiun Suk Chae (Uijeongbu), Young-Eun Joo (Gwangju)
11:10-11:20 Risk factors including fecal markers for hospitalization in patients with ulcerative colitis Byung Jin Kwon
(Yangsan)
11:20-11:30 Mucosal healing is associated with transmural healing after 1-year treatment with anti-TNF agents in pediatric Crohn's disease patients Ben Kang
(Daegu)
11:30-11:40 Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on adalimumab maintenance therapy Eun Hye Oh
(Seoul)
11:40-12:00 Keynote Lecuture: Evolving monitoring for IBD patient care in clinical practice Byung Ik Jang
(Daegu)
Symposium GI-02 (UG)
Nov. 16 (Fri)
14:00-15:30
Gastric carcinogenesis: Host, microbiome, and their interactions 101 (1F)
Chairperson(s) Kwong Ming Fock (Singapore), Ki Baik Hahm (Seongnam)
14:00-14:20 Identification of genetic susceptibility for gastric cancer through genome-wide association studies Benjamin Wong
(Hong Kong)
14:20-14:40 Non-coding RNA and gastric cancer Sang Kil Lee
(Seoul)
14:40-15:00 Interactions between human and Helicobacter pylori in gastric carcinogenesis Richard Peek
(Nashville)
15:00-15:20 Non-Helicobacter pylori microbiome in gastric carcinogenesis Yoshio Yamaoka
(Yufu)
15:20-15:30 Q&As
Symposium GI-03 (LG)
Nov. 16 (Fri)
14:00-15:30
Shifting paradigm in IBD management 202 (2F)
Chairperson(s) Joo Sung Kim (Seoul), Siew Chien Ng (Hong Kong)
14:00-14:20 New drugs on the horizon: Targeting cytokines, cell trafficking, and more Choon Jin Ooi
(Singapore)
14:20-14:40 Fecal microbiota transplantation for IBD: Ready to use? Siew Chien Ng
(Hong Kong)
14:40-15:00 Toward improving quality of care in IBD management David Todd Rubin
(Chicago)
15:00-15:20 Things you should know when managing elderly IBD patients Jae Hee Cheon
(Seoul)
15:20-15:30 Q&As
Symposium GI-04 (GI Cancer)
Nov. 16 (Fri)
14:00-15:30
Gastirc cancer, are we in new era for management? E1+2 (3F)
Chairperson(s) Hyunyong Jeong (Daejeon), James R. Goldenring (Nashville)
14:00-14:20 The global change in epidemiology of gastric cancer Jin Young Park
(Lyon)
14:20-14:40 Role of?SPEM in gastric carcinogenesis James R. Goldenring
(Nashville)
14:40-15:00 Do we have proper surgical modalities to preserve functional aspect after gastric cancer surgery? Keun Won Ryu
(Goyang)
15:00-15:20 Current treatment landscape and future perspectives in patients with advanced gastric cancer Sung Eun Kim
(Busan)
15:20-15:30 Q&As
KDDW Free Paper (LG 3) (Korean)
Nov. 16 (Fri)
14:00-15:30
KDDW Free Paper (LG 3) E5 (3F)
Chairperson(s) Kooklae Lee (Seoul), Soon Man Yoon (Cheongju)
14:00-14:10 Cost drivers for inflammatory bowel disease care: a population-based study using the korean national health insurance claims data (2006-2015) Jung-Wook Kim
(Seoul)
14:10-14:20 Real life effectiveness and safety of vedolizumab as induction therapy for Korean IBD patients in whom anti-TNF treatment failed: A prospective cohort study Jeongseok Kim
(Seoul)
14:20-14:30 Influence of Vitamin D status on the clinical course of ulcerative colitis Nam Seok Ham
(Seoul)
Chairperson(s) Moon Sung Lee (Bucheon), Bo-In Lee (Seoul)
14:30-14:40 Impact of family history of colorectal cancer on age-specific prevalence of colorectal Seulki Kim
(Seoul)
14:40-14:50 The association of cigarette smoking and alcohol consumption with sessile serrated adenoma in 30-49 year-old subjects Ji Young Lee
(Seoul)
14:50-15:00 prevalence of and risk factors for colorectal neoplasia in asymptomatic young adults aged 20 to 39 years Jin Ju Song
(Seoul)
15:00-15:10 Does colon diverticulosis raise the risk of adenomatous colon polyp in patients with colorectal cancer? Suyun Oh
(Suwon)
Symposium GI-05 (LG)
Nov. 16 (Fri)
16:00-17:30
The cutting edge issues in management of IBD 2018 102 (1F)
Chairperson(s) Suk-Kyun Yang (Seoul), Jiaming Qian (Beijing)
16:00-16:20 What should be the therapeutic targets in IBD therapy? Siew Chien Ng
(Hong Kong)
16:20-16:40 Proper positioning of various drugs in therapeutic algorithm David Todd Rubin
(Chicago)
16:40-17:00 Place of TDM in optimal use of biologics Akira Andoh
(Otsu)
17:00-17:20 Managing Crohn's disease after surgery Kang-Moon Lee
(Suwon)
17:20-17:30 Q&As
Symposium GI-06 (UG)
Nov. 16 (Fri)
16:00-17:30
All about GIST on UGI tract 202 (2F)
Chairperson(s) Chang-Hun Yang (Gyeongju), Byung-Wook Kim (Incheon)
16:00-16:20 Pathologic diagnosis; focused on prognostic factor Gu Hyun Kang
(Seoul)
16:20-16:40 Endoscopic treatment: when and how? Hanglak Lee
(Seoul)
16:40-17:00 Surgical treatment: when and how? Hyundong Chae
(Daegu)
17:00-17:20 Target therapy: when and how? Dong-Hoe Koo
(Seoul)
17:20-17:30 Q&As
PG Course-LG (Korean)
Nov. 16 (Fri)
16:00-17:30
Current status and future perspectives in management of small bowel diseases E1+2 (3F)
Chairperson(s) Hyun Soo Kim (Gwangju), Sung-Ae Jung (Seoul)
16:00-16:20 Optimal approach to small bowel bleeding Hyun Jung Lee
(Seoul)
16:20-16:40 Radiologic diagnosis of small bowel diseases Jeong Kyong Lee
(Seoul)
16:40-17:00 Therapeutic role of enteroscopy Sung Noh Hong
(Seoul)
17:00-17:20 Interesting cases of various small bowel diseases Bong Min Ko
(Bucheon)
17:20-17:30 Q&As
Symposium GI-07 (LG)
Nov. 17 (Sat)
08:30-10:00
Updates on the management of gastrointestinal bleeding 103 (1F)
Chairperson(s) Toshiyuki Matsui (Chikushino), Michael Ka Wah Li (Hong Kong)
08:30-08:50 Treatment of peptic ulcer bleeding: present and future Yunsheng Yang
(Beijing)
08:50-09:10 Diagnostic approach for obscure gastrointestinal bleeding Ki-Nam Shim
(Seoul)
09:10-09:30 Endoscopic management of colonic diverticular bleeding Hiroshi Kashida
(Osaka)
09:30-09:50 Treatment and prevention of Variceal bleeding Shiv Kumar Sarin
(New Delhi)
09:50-10:00 Q&As
Symposium GI-08(UG)
Nov. 17 (Sat)
10:30-12:00
GERD: new diagnostic approach and management in 2018 103 (1F)
Chairperson(s) Sabine Roman (Lyon), Young-Tae Bak (Seoul)
10:30-10:50 Pathophysiology of GERD: what’s new in 2018? John Pandolfino
(Wilmette)
10:50-11:10 Novel diagnostic approach of GERD: From Ascona to Lyon consensus Sabine Roman
(Lyon)
11:10-11:30 The risk and benefits of long-term use of PPIs Poong-Lyul Rhee
(Seoul)
11:30-11:50 Potassium-competitive acid blockers (P-CAB): Advanced therapeutic option for GERD George Sachs
(Los Angeles)
11:50-12:00 Q&As
Symposium GI-09 (LG)
Nov. 17 (Sat)
14:00-15:30
What are the special issues of IBD in Asians? 102 (1F)
Chairperson(s) Mamoru Watanabe (Tokyo), Hyo Jong Kim (Seoul)
14:00-14:20 Pathophysiologic mechanisms: Genetics and serology in Asian IBD patients Byong Duk Ye
(Seoul)
14:20-14:40 Differential diagnosis of IBD and IBD mimics in Asia Shu Chen Wei
(Taipei)
14:40-15:00 Prognostication of Asian IBD patients: Different from Westerns? Zhihua Ran
(Shanghai)
15:00-15:20 Therapueutic algorithm in Asia vs. Western: Similarities and differences Katsuyoshi Matsuoka
(Sakura)
15:20-15:30 Q&As
Symposium GI-10 (GI Cancer)
Nov. 17 (Sat)
14:00-15:30
Emerging armamentarium for the management of GI cancer 203 (2F)
Chairperson(s) Myunghwan Noh (Busan), Seun Ja Park (Busan)
14:00-14:20 Liquid biopsies: technology overview and clinical implications Dong Uk Kim
(Busan)
14:20-14:40 Revisiting an old weapon: HIPEC for GI cancer Seung Hyuk Baik
(Seoul)
14:40-15:00 Immune therapy: Is this ready for use in GI cancer? Yusuke Hashimoto
(Kashiwa)
15:00-15:20 Proton beam therapy or Particle beam therapy Tae Hyun Kim
(Goyang)
15:20-15:30 Q&As
Symposium GI-11 (UG)
Nov. 17 (Sat)
16:00-17:30
What clinicians need to know in ROME IV? 101 (1F)
Chairperson(s) Kentaro Sugano (Shimotsuke), Justin CY Wu (Hong Kong)
16:00-16:20 Introduction and overview Nicholas J Talley
(Newcastle)
16:20-16:40 Esophageal disorders Hiroto Miwa
(Nishinomiya)
16:40-17:00 Gastroduodenal disorders Nicholas J Talley
(Newcastle)
17:00-17:20 Bowel disorders Suck Chei Choi
(Iksan)
17:20-17:30 Q&As
Symposium GI-12 (LG)
Nov. 17 (Sat)
16:00-17:30
Emerging issues in colorectal cancer screening in Asian-Pacific region 102 (1F)
Chairperson(s) Khean Lee Goh (Kuala Lumpur), Uri Ladabaum (Redwood)
16:00-16:20 Early-onset colorectal cacner in Asia-Pacific Hyun-Soo Kim
(Wonju)
16:20-16:40 Recent updates in biological markers in colorectal cancer screening Joseph J Y Sung
(Hong Kong)
16:40-17:00 Obstacles and inequities in colorectal cancer screening in Asian-Pacific regions Han-Mo Chiu
(Taipei)
17:00-17:20 Cost-effectiveness of colorectal cancer screening Hermann Brenner
(Heidelberg)
17:20-17:30 Q&As
Symposium GI-13 (UG)
Nov. 18 (Sun)
10:30-12:00
Recent issues in diagnostic and therapeutic endoscopy 101 (1F)
Chairperson(s) Hoon Jai Chun (Seoul), Kenshi Yao (Chikushino)
10:30-10:50 E-learning system for increasing diagnostic performance in early gastric cancer Kenshi Yao
(Chikushino)
10:50-11:10 Robot-assisted endoscopic resection Khek Yu Ho
(Singapore)
11:10-11:30 Quality of ESD: It's time to look back Seiichiro Abe
(Tokyo)
11:30-11:50 Satety of endoscopic treatment for GISTs Jong-Jae Park
(Seoul)
11:50-12:00 Q&As
Symposium GI-14 (UG)
Nov. 18 (Sun)
10:30-12:00
Current understanding of peptic ulcer disease 103 (1F)
Chairperson(s) Jaw-Town Lin (Taipei), Yong Chan Lee (Seoul), Ian Roberts-Thomson (Hawthorn)
10:30-10:50 Pathophysiology and treatment of peptic ulcer Varocha Mahachai
(Bangkok)
10:50-11:10 Helicobacter-negative peptic ulcer: the prevention and treatment Khien Van Vu
(Hanoi)
11:10-11:30 GI bleeding in the era of direct oral anticoagulants Akiko Shiotani
(Kurashiki)
11:30-11:50 Endoscopic management of peptic ulcer bleeding: recent update Sunny Wong
(Hong Kong)
11:50-12:00 Q&As
Symposium GI-15 (LG)
Nov. 18 (Sun)
13:30-15:00
IBS: update 2018 103 (1F)
Chairperson(s) Minhu Chen (Guangzhou), Oh Young Lee (Seoul)
13:30-13:50 Low FODMAP diet: what we know in 2018 Peter Gibson
(Melbourne)
13:50-14:10 Post-infectious IBS: its mechanism and clinical course Hyojin Park
(Seoul)
14:10-14:30 Psychosomatic approach for IBS Shin Fukudo
(Sendai)
14:30-14:50 Microbiota in IBS: friend or foe? Eamonn Quigley
(Houston)
14:50-15:00 Q&As

Go to Top

Supported by
Member Societies
  • President : Dong Ki Lee
  • Business License No. 106-82-07189

Copyright© 2008 The Korean Society of Gastroenterlogy. All Rights Reserved.

Room 305, 31 Seolleung-ro 86 gil, Gangnam-gu, Seoul, 06193, Korea
Associated Societies
Secretariat